Effectiveness and Adverse Events of Tolvaptan in Octogenarians With Heart Failure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness and Adverse Events of Tolvaptan in Octogenarians With Heart Failure

Published:2015 Issue:2 Volume:56 Page:137-143
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Kinugawa Koichiro¹,Inomata Takayuki²,Sato Naoki³,Yasuda Moriyoshi⁴,Shimakawa Toshiyuki⁴,Bando Kosuke⁴,Mizuguchi Kazuki⁴

Affiliation:

1. Department of Therapeutic Strategy for Heart Failure, Graduate School of Medicine, The University of Tokyo

2. Department of Cardiovascular Medicine, Kitasato University School of Medicine

3. Department of Internal Medicine and Cardiology, Nippon Medical School Musashi-Kosugi Hospital

4. Otsuka Pharmaceutical Co., Ltd

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference16 articles.

1. 1. Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-402.

2. 2. Pocock SJ, Wang D, Pfeffer MA, et al. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006; 27: 65-75.

3. 3. Abraham WT, Fonarow GC, Albert NM, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 2008; 52: 347-56.

4. 4. Barsheshet A, Shotan A, Cohen E, et al. Predictors of long-term (4-year) mortality in elderly and young patients with acute heart failure. Eur J Heart Fail 2010; 12: 833-40.

5. 5. Hülsmann M, Berger R, Mörtl D, Pacher R. Influence of age and in-patient care on prescription rate and long-term outcome in chronic heart failure: a data-based substudy of the EuroHeart Failure Survey. Eur J Heart Fail 2005; 7: 657-61.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of early administration of tolvaptan on pleural effusion post-hepatectomy;Langenbeck's Archives of Surgery;2023-10-16

2. Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure;Journal of Clinical Medicine;2023-04-24

3. Early Commencement and Long-Term Continuation of Tolvaptan Treatment Attenuate Functional Impairment of Renal Vasopressin V2 Receptors and Improve Clinical Outcomes in Patients with Heart Failure;International Heart Journal;2023-03-31

4. Effect of early administration of tolvaptan on pleural effusion post-hepatectomy;2023-03-16

5. Trends in tolvaptan prescription and the association between hypernatremia and aging in tolvaptan-treated patients in Japan: Real-world data mining using Japanese databases;Int. Journal of Clinical Pharmacology and Therapeutics;2023-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3